REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions

REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Proceedings of the National Academy of Sciences - PNAS 2020-05, Vol.117 (21), p.11202-11203
Hauptverfasser: Malinow, Roberto, Klein, Matthew E.
Format: Artikel
Sprache:eng
Schlagworte:
Antidepressants
Biological Sciences
Ketamine
LETTERS
Opioids
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 11203
container_issue 21
container_start_page 11202
container_title Proceedings of the National Academy of Sciences - PNAS
container_volume 117
creator Malinow, Roberto
Klein, Matthew E.
description
doi_str_mv 10.1073/pnas.2002739117
format Article
fullrecord <record><control><sourceid>jstor_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7260948</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><jstor_id>26930935</jstor_id><sourcerecordid>26930935</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-98e0b54f1b379424252b98da1c3ea746ebcf36cb99d3d8d35ca5e330fe72f8d33</originalsourceid><addsrcrecordid>eNpdkD1PwzAQhi0EoqWwsDCBKrGwhJ59dhwvSFVVaKWiICgDk-UkDqRqkxInSPx7ErWUj8my7_F7dw8hZxSuKUgcrHPjrhkAk6golXukS0FRz-cK9km3ffcCzniHHDm3AAAlAjgkHWQcAZnsktPH8cPspT8P-5Ph02R6H87DY3KQmqWzJ9uzR55vx_PRxJuFd9PRcObFnGPlqcBCJHhKI5Sq6cEEi1SQGBqjNZL7NopT9ONIqQSTIEERG2ERIbWSpc0de-Rmk7uuo5VNYptXpVnqdZmtTPmpC5Ppv5U8e9OvxYeWzAfFgybgahtQFu-1dZVeZS62y6XJbVE7zTgIBOFL1qCX_9BFUZd5s15LSeQ0aJT0yGBDxWXhXGnT3TAUdOtbt771j-_mx8XvHXb8t-AGON8AC1cV5a7OfIWgUOAXrGSCHQ</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2407341824</pqid></control><display><type>article</type><title>REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions</title><source>JSTOR Archive Collection A-Z Listing</source><source>PubMed Central</source><source>Alma/SFX Local Collection</source><source>Free Full-Text Journals in Chemistry</source><creator>Malinow, Roberto ; Klein, Matthew E.</creator><creatorcontrib>Malinow, Roberto ; Klein, Matthew E.</creatorcontrib><identifier>ISSN: 0027-8424</identifier><identifier>EISSN: 1091-6490</identifier><identifier>DOI: 10.1073/pnas.2002739117</identifier><identifier>PMID: 32430327</identifier><language>eng</language><publisher>United States: National Academy of Sciences</publisher><subject>Antidepressants ; Biological Sciences ; Ketamine ; LETTERS ; Opioids</subject><ispartof>Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (21), p.11202-11203</ispartof><rights>Copyright National Academy of Sciences May 26, 2020</rights><rights>2020</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c443t-98e0b54f1b379424252b98da1c3ea746ebcf36cb99d3d8d35ca5e330fe72f8d33</citedby><cites>FETCH-LOGICAL-c443t-98e0b54f1b379424252b98da1c3ea746ebcf36cb99d3d8d35ca5e330fe72f8d33</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.jstor.org/stable/pdf/26930935$$EPDF$$P50$$Gjstor$$H</linktopdf><linktohtml>$$Uhttps://www.jstor.org/stable/26930935$$EHTML$$P50$$Gjstor$$H</linktohtml><link.rule.ids>230,314,727,780,784,803,885,27924,27925,53791,53793,58017,58250</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32430327$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Malinow, Roberto</creatorcontrib><creatorcontrib>Klein, Matthew E.</creatorcontrib><title>REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions</title><title>Proceedings of the National Academy of Sciences - PNAS</title><addtitle>Proc Natl Acad Sci U S A</addtitle><subject>Antidepressants</subject><subject>Biological Sciences</subject><subject>Ketamine</subject><subject>LETTERS</subject><subject>Opioids</subject><issn>0027-8424</issn><issn>1091-6490</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><recordid>eNpdkD1PwzAQhi0EoqWwsDCBKrGwhJ59dhwvSFVVaKWiICgDk-UkDqRqkxInSPx7ErWUj8my7_F7dw8hZxSuKUgcrHPjrhkAk6golXukS0FRz-cK9km3ffcCzniHHDm3AAAlAjgkHWQcAZnsktPH8cPspT8P-5Ph02R6H87DY3KQmqWzJ9uzR55vx_PRxJuFd9PRcObFnGPlqcBCJHhKI5Sq6cEEi1SQGBqjNZL7NopT9ONIqQSTIEERG2ERIbWSpc0de-Rmk7uuo5VNYptXpVnqdZmtTPmpC5Ppv5U8e9OvxYeWzAfFgybgahtQFu-1dZVeZS62y6XJbVE7zTgIBOFL1qCX_9BFUZd5s15LSeQ0aJT0yGBDxWXhXGnT3TAUdOtbt771j-_mx8XvHXb8t-AGON8AC1cV5a7OfIWgUOAXrGSCHQ</recordid><startdate>20200526</startdate><enddate>20200526</enddate><creator>Malinow, Roberto</creator><creator>Klein, Matthew E.</creator><general>National Academy of Sciences</general><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QG</scope><scope>7QL</scope><scope>7QP</scope><scope>7QR</scope><scope>7SN</scope><scope>7SS</scope><scope>7T5</scope><scope>7TK</scope><scope>7TM</scope><scope>7TO</scope><scope>7U9</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>H94</scope><scope>M7N</scope><scope>P64</scope><scope>RC3</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20200526</creationdate><title>REPLY TO HASHIMOTO</title><author>Malinow, Roberto ; Klein, Matthew E.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-98e0b54f1b379424252b98da1c3ea746ebcf36cb99d3d8d35ca5e330fe72f8d33</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Antidepressants</topic><topic>Biological Sciences</topic><topic>Ketamine</topic><topic>LETTERS</topic><topic>Opioids</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Malinow, Roberto</creatorcontrib><creatorcontrib>Klein, Matthew E.</creatorcontrib><collection>PubMed</collection><collection>CrossRef</collection><collection>Animal Behavior Abstracts</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Calcium &amp; Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Ecology Abstracts</collection><collection>Entomology Abstracts (Full archive)</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Nucleic Acids Abstracts</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>Genetics Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Malinow, Roberto</au><au>Klein, Matthew E.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions</atitle><jtitle>Proceedings of the National Academy of Sciences - PNAS</jtitle><addtitle>Proc Natl Acad Sci U S A</addtitle><date>2020-05-26</date><risdate>2020</risdate><volume>117</volume><issue>21</issue><spage>11202</spage><epage>11203</epage><pages>11202-11203</pages><issn>0027-8424</issn><eissn>1091-6490</eissn><cop>United States</cop><pub>National Academy of Sciences</pub><pmid>32430327</pmid><doi>10.1073/pnas.2002739117</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0027-8424
ispartof Proceedings of the National Academy of Sciences - PNAS, 2020-05, Vol.117 (21), p.11202-11203
issn 0027-8424
1091-6490
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7260948
source JSTOR Archive Collection A-Z Listing; PubMed Central; Alma/SFX Local Collection; Free Full-Text Journals in Chemistry
subjects Antidepressants
Biological Sciences
Ketamine
LETTERS
Opioids
title REPLY TO HASHIMOTO: Ketamine is not an opioid but requires opioid system for antidepressant actions
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-24T03%3A34%3A24IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-jstor_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=REPLY%20TO%20HASHIMOTO:%20Ketamine%20is%20not%20an%20opioid%20but%20requires%20opioid%20system%20for%20antidepressant%20actions&rft.jtitle=Proceedings%20of%20the%20National%20Academy%20of%20Sciences%20-%20PNAS&rft.au=Malinow,%20Roberto&rft.date=2020-05-26&rft.volume=117&rft.issue=21&rft.spage=11202&rft.epage=11203&rft.pages=11202-11203&rft.issn=0027-8424&rft.eissn=1091-6490&rft_id=info:doi/10.1073/pnas.2002739117&rft_dat=%3Cjstor_pubme%3E26930935%3C/jstor_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2407341824&rft_id=info:pmid/32430327&rft_jstor_id=26930935&rfr_iscdi=true